Physician profile
Daniel Brunner
NPI 1811492622
$23,803.93
in general payments reported to CMS, 2019-2025
12 companies · $38.21 in 2025
The $38.21 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $102 · 2022: $13K · 2023: $11K · 2024: $166 · 2025: $38.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $1,004.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22,070.83 | 2021-2024 | Synchromedii, Intellis Adaptivestim |
| Abbott Laboratories | $607.84 | 2022-2024 | Proclaim |
| Spr Therapeutics, INC | $273.87 | 2023-2024 | Sprint Pns System |
| Nevro Corp. | $254.74 | 2022-2023 | Senza |
| Painteq LLC | $237.17 | 2023 | Painteq |
| Vertos Medical, INC. | $150.00 | 2023 | Mild Device Kit |
| Heron Therapeutics, INC. | $69.07 | 2021 | |
| Stryker Corporation | $48.96 | 2023-2025 | N/A, Mild Device Kit, Optablate |
| Abbvie INC. | $34.28 | 2023 | Botox |
| Bioventus LLC | $23.96 | 2023 | Stimrouter Implantable Kit |
| Boston Scientific Corporation | $17.79 | 2022 | |
| Glaxosmithkline, LLC. | $15.42 | 2025 | Benlysta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Brunner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.